NTRK1 and neoplasm: On the other hand, CD271 has been proposed as a marker of tumor-initiating-cells in oral human and murine SCC cells, and CD271 activation by NGF results in a more invasive phenotype [62], most likely involving Trk-CD271 heterodimer signaling.